![Albuterol via metered‐dose inhaler in children: Lower doses are effective, and higher doses are safe - Muchão - 2016 - Pediatric Pulmonology - Wiley Online Library Albuterol via metered‐dose inhaler in children: Lower doses are effective, and higher doses are safe - Muchão - 2016 - Pediatric Pulmonology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/3da3e003-07d0-47ee-8c77-8739fb21eaad/ppul23469-fig-0001-m.jpg)
Albuterol via metered‐dose inhaler in children: Lower doses are effective, and higher doses are safe - Muchão - 2016 - Pediatric Pulmonology - Wiley Online Library
![Continuous versus intermittent short-acting β2-agonists nebulization as first-line therapy in hospitalized children with severe asthma exacerbation: a propensity score matching analysis | Asthma Research and Practice | Full Text Continuous versus intermittent short-acting β2-agonists nebulization as first-line therapy in hospitalized children with severe asthma exacerbation: a propensity score matching analysis | Asthma Research and Practice | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs40733-020-00059-5/MediaObjects/40733_2020_59_Fig1_HTML.png)
Continuous versus intermittent short-acting β2-agonists nebulization as first-line therapy in hospitalized children with severe asthma exacerbation: a propensity score matching analysis | Asthma Research and Practice | Full Text
![Albuterol Sulfate Inhalation Solution0.042% (1.25 mg*/3 mL) and 0.021% (0.63 mg*/3 mL)(*Potency expressed as albuterol, equivalent to 1.5 mgand 0.75 mg albuterol sulfate) Revised: January 2017 Rx only Albuterol Sulfate Inhalation Solution0.042% (1.25 mg*/3 mL) and 0.021% (0.63 mg*/3 mL)(*Potency expressed as albuterol, equivalent to 1.5 mgand 0.75 mg albuterol sulfate) Revised: January 2017 Rx only](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-9.jpg&id=427002)
Albuterol Sulfate Inhalation Solution0.042% (1.25 mg*/3 mL) and 0.021% (0.63 mg*/3 mL)(*Potency expressed as albuterol, equivalent to 1.5 mgand 0.75 mg albuterol sulfate) Revised: January 2017 Rx only
![PDF] The conversion to metered-dose inhaler with valved holding chamber to administer inhaled albuterol: a pediatric hospital experience. | Semantic Scholar PDF] The conversion to metered-dose inhaler with valved holding chamber to administer inhaled albuterol: a pediatric hospital experience. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c68aa2399ed2c2fdcb1c686e8756eb6af886514e/5-Table2-1.png)
PDF] The conversion to metered-dose inhaler with valved holding chamber to administer inhaled albuterol: a pediatric hospital experience. | Semantic Scholar
![Albuterol Sulfate Inhalation Solution0.042% (1.25 mg*/3 mL) and 0.021% (0.63 mg*/3 mL)(*Potency expressed as albuterol, equivalent to 1.5 mgand 0.75 mg albuterol sulfate) Revised: January 2017 Rx only Albuterol Sulfate Inhalation Solution0.042% (1.25 mg*/3 mL) and 0.021% (0.63 mg*/3 mL)(*Potency expressed as albuterol, equivalent to 1.5 mgand 0.75 mg albuterol sulfate) Revised: January 2017 Rx only](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-8.jpg&id=427002)
Albuterol Sulfate Inhalation Solution0.042% (1.25 mg*/3 mL) and 0.021% (0.63 mg*/3 mL)(*Potency expressed as albuterol, equivalent to 1.5 mgand 0.75 mg albuterol sulfate) Revised: January 2017 Rx only
![Safe and Effective Use of Score-Based Continuous Albuterol Therapy in a Pathway for Treatment of Pediatric Asthma Exacerbation | Respiratory Care Safe and Effective Use of Score-Based Continuous Albuterol Therapy in a Pathway for Treatment of Pediatric Asthma Exacerbation | Respiratory Care](https://rc.rcjournal.com/content/respcare/67/11/1396/F1.large.jpg)
Safe and Effective Use of Score-Based Continuous Albuterol Therapy in a Pathway for Treatment of Pediatric Asthma Exacerbation | Respiratory Care
![PDF] Nebulizers vs metered-dose inhalers with spacers for bronchodilator therapy to treat wheezing in children aged 2 to 24 months in a pediatric emergency department. | Semantic Scholar PDF] Nebulizers vs metered-dose inhalers with spacers for bronchodilator therapy to treat wheezing in children aged 2 to 24 months in a pediatric emergency department. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1fef1372be98e8bfb5ba78f8f8f8f6b8feef9b7a/3-Table2-1.png)
PDF] Nebulizers vs metered-dose inhalers with spacers for bronchodilator therapy to treat wheezing in children aged 2 to 24 months in a pediatric emergency department. | Semantic Scholar
![Albuterol Sulfate Inhalation Solution0.042% (1.25 mg*/3 mL) and 0.021% (0.63 mg*/3 mL)(*Potency expressed as albuterol, equivalent to 1.5 mgand 0.75 mg albuterol sulfate) Revised: January 2017 Rx only Albuterol Sulfate Inhalation Solution0.042% (1.25 mg*/3 mL) and 0.021% (0.63 mg*/3 mL)(*Potency expressed as albuterol, equivalent to 1.5 mgand 0.75 mg albuterol sulfate) Revised: January 2017 Rx only](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-7.jpg&id=427002)
Albuterol Sulfate Inhalation Solution0.042% (1.25 mg*/3 mL) and 0.021% (0.63 mg*/3 mL)(*Potency expressed as albuterol, equivalent to 1.5 mgand 0.75 mg albuterol sulfate) Revised: January 2017 Rx only
![Albuterol Sulfate by Hi-Tech Pharmacal Co., Inc. / Akorn Operating Company LLC ALBUTEROL SULFATE syrup Albuterol Sulfate by Hi-Tech Pharmacal Co., Inc. / Akorn Operating Company LLC ALBUTEROL SULFATE syrup](https://fda.report/DailyMed/d3544356-e36a-4ce6-8235-cb0531c658ad/image-02.jpg)